Legend Biotech Files 6-K Report

Ticker: LEGN · Form: 6-K · Filed: Mar 11, 2025 · CIK: 1801198

Legend Biotech Corp 6-K Filing Summary
FieldDetail
CompanyLegend Biotech Corp (LEGN)
Form Type6-K
Filed DateMar 11, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, regulatory, foreign-private-issuer

TL;DR

Legend Biotech filed a routine 6-K on 3/11/25, confirming 20-F annual report filings.

AI Summary

Legend Biotech Corp filed a Form 6-K on March 11, 2025, reporting its status as a foreign private issuer. The company, incorporated in E9 with its principal executive offices in Somerset, New Jersey, indicated it files annual reports under Form 20-F.

Why It Matters

This filing confirms Legend Biotech's reporting status and adherence to SEC regulations for foreign private issuers, which impacts how and when they disclose financial information.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically affect risk.

Key Players & Entities

  • Legend Biotech Corp (company) — Filer of the 6-K report
  • March 11, 2025 (date) — Date of the report filing
  • Somerset, New Jersey (location) — Location of principal executive office
  • Form 20-F (document) — Annual report filing type
  • Form 6-K (document) — Type of report filed

FAQ

What is the primary purpose of this Form 6-K filing by Legend Biotech Corp?

The primary purpose is to report its status as a foreign private issuer and confirm that it files annual reports under cover of Form 20-F.

When was this Form 6-K filed with the SEC?

This Form 6-K was filed on March 11, 2025.

Where are Legend Biotech Corporation's principal executive offices located?

Legend Biotech Corporation's principal executive offices are located at 2101 Cottontail Lane, Somerset, New Jersey, 08873.

Does Legend Biotech indicate it is submitting this Form 6-K in paper format?

The filing includes checkboxes for paper submission under Regulation S-T Rule 101(b)(1) and 101(b)(7), but the presence of 'X' next to Form 20-F suggests it is not solely submitting an annual report in paper.

What is Legend Biotech's SIC code?

Legend Biotech's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on March 11, 2025 regarding Legend Biotech Corp (LEGN).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.